Stock Events

AddLife AB 

$42
7
+$0+0% Tuesday 20:00

Statistics

Day High
7.94
Day Low
7.94
52W High
42
52W Low
7.94
Volume
3,744
Avg. Volume
0
Mkt Cap
4.92B
P/E Ratio
61.76
Dividend Yield
0.11%
Dividend
0.05

Upcoming

Dividends

0.11%Dividend Yield
10Y Growth
N/A
5Y Growth
-4.01%
3Y Growth
-36.02%
1Y Growth
N/A

Earnings

23OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0
0.51
1.01
1.52
Expected EPS
1.1985797708450001
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ADDLF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Danaher
DHR
Mkt Cap194.5B
Danaher Corporation operates in the life sciences sector, offering similar products and services for research and clinical applications, directly competing with AddLife's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, closely aligning with AddLife's market.
Agilent Technologies
A
Mkt Cap41.06B
Agilent Technologies, Inc. supplies instruments, software, services, and consumables for the entire laboratory workflow, competing in the same space as AddLife AB.
Bio-Rad Laboratories
BIO
Mkt Cap9.35B
Bio-Rad Laboratories, Inc. produces and distributes products for a wide range of research and clinical diagnostic applications, making it a direct competitor to AddLife.
Waters
WAT
Mkt Cap20.56B
Waters Corporation designs, manufactures, and sells analytical standards and instruments, competing in the life sciences and diagnostics markets similar to AddLife.
PERKINELMER INC
PKI
Mkt Cap16.9B
PerkinElmer, Inc. provides products and services for the diagnostics, life sciences, and applied services markets, overlapping with AddLife's target markets.
Bruker
BRKR
Mkt Cap10.17B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions that compete with AddLife's product offerings.
Resmed
RMD
Mkt Cap36B
ResMed Inc. specializes in cloud-connected medical devices for sleep apnea, COPD, and other chronic diseases, offering some products and services that compete with AddLife's.
Bio-Techne
TECH
Mkt Cap11.73B
Bio-Techne Corporation develops, manufactures, and sells biotechnology products and clinical calibrators and controls, competing in the biotech and clinical sectors like AddLife.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights, directly competing in the diagnostics and research market with AddLife.

About

Medical Distributors
Distribution Services
AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
Show more...
CEO
Kristina Willgard
Employees
2289
Country
SE
ISIN
SE0014401378

Listings